An in vivo platform to identify pathogenic loci

Area of Science:

• Genetics
• Model Organisms
• Disease Gene Discovery

Background:

• Rare genetic diseases often result in the identification of novel disease genes.
• The PreMIER Consortium evaluates human genetic variants in model systems.
• Over 50 variants have been assessed in patients with genetic disorders by the PreMIER Consortium.

Approach:

• This study investigates the utility of Drosophila as a model system for identifying pathogenic disease loci within the PreMIER Consortium.
• A proof-of-principle experiment utilized tissue-specific gene knockdown in Drosophila.
• Seven conserved disease genes were targeted for knockdown.

Key Points:

• Tissue-specific knockdown of conserved disease genes in Drosophila induced significant alterations in viability, longevity, behavior, motor function, and neuronal survival.
• A standardized set of assays can determine if a gene of uncertain significance (GUS) influences physiological processes.
• This demonstrates the effectiveness of Drosophila in characterizing GUS.

Conclusions:

• Drosophila serves as a valuable model system for functional evaluation of human genetic variants.
• The tissue-specific knockdown platform in Drosophila can establish initial genotype-phenotype correlations for patients with idiopathic genetic disorders.
• This approach aids in understanding the pathogenicity of genes of uncertain significance.